Healthcare -
Biotechnology - NASDAQ - US
$ 6.02
-3.06 %
$ 1.83 B
Market Cap
-4.07
P/E
IOVA - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities IOVA - Iovance Biotherapeutics, Inc.
463 M
LAST VALUE
39.10%
2 YEAR CAGR
1.76%
5 YEAR CAGR
34.81%
10 YEAR CAGR